Article Details

FY2022 EPS Estimates for Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Decreased by Analyst

Retrieved on: 2022-11-28 06:19:52

Tags for this article:

Click the tags to see associated articles and topics

FY2022 EPS Estimates for Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) Decreased by Analyst. View article details on HISWAI: https://reporter.am/2022/11/28/fy2022-eps-estimates-for-aridis-pharmaceuticals-inc-nasdaqards-decreased-by-analyst.html

Excerpt

... on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections.

Article found on: reporter.am

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up